Cochlear Launches World’s Smallest Off-the-ear Cochlear Implant Sound Processor in Singapore, Advancing Performance and Connectivity
- Nucleus® Kanso® 2 Sound Processor is the world’s smallest* off-the-ear cochlear implant sound processor with proven hearing performance technologies.
- It is the first and only off-the-ear cochlear implant sound processor to offer direct streaming from compatible Apple or Android™ devices.
- New technology showcases Cochlear’s commitment to improving hearing outcomes and quality of life for people with hearing loss.
Singapore, 27 August 2021 – Cochlear Limited (ASX:COH), the global leader in implantable hearing solutions, today announced the launch of the Nucleus® Kanso® 2 Sound Processor in Singapore. The new launch reflects Cochlear’s ongoing commitment to innovation in hearing technology to provide amplified access to smartphone connectivity and helping to improve hearing performance in people with hearing loss.
Amy Zheng, General Manager, Southeast Asia, Cochlear, said, “Cochlear is dedicated to bringing sound to people all over the world. The Nucleus Kanso 2 Sound Processor showcases Cochlear’s latest and most advanced hearing performance technology, and marks a new step towards helping people in Singapore living with hearing loss to hear better. With its latest connectivity features and simple design, this new technology is designed to better meet the different needs and lifestyles of individuals and is the result of persistent efforts to improve hearing outcomes.”
The Nucleus Kanso 2 Sound Processor is the world’s smallest off-the-ear cochlear implant sound processor with proven hearing performance technologies*. It is the first and only off-the-ear cochlear implant sound processor to offer direct streaming from compatible Apple or Android™ devices*, and is compatible with the Nucleus Smart App*, enabling control of device settings, functions and information.
The Kanso 2 Sound Processor features an integrated rechargeable battery* and the highest possible water resistance rating† for any off-the-ear cochlear implant sound processor, giving users the freedom to live an active lifestyle.
To help users hear more of what they want to listen to, the Nucleus Kanso 2 Sound Processor features proven hearing performance technologies*. Dual microphones filter out background noise to help provide better hearing performance in noise compared to a single microphone*. With ForwardFocus*, users can reduce noise from behind them to help them focus on conversations in front of them*. SmartSound® IQ with SCAN helps users to hear more clearly in a range of listening environments by capturing sound through dual microphones, analysing surroundings, before automatically adjusting the settings for the hearing conditions*.
The Kanso 2 Sound Processor features a simple, durable all-in-one design, that makes it easy to use – its unique button-free control with an automatic on/off function helps simplify the experience.
Ensuring connectivity during a pandemic
Studies have shown that patients with hearing loss may be two to five times more likely to develop dementia, depending on the severity of their hearing problems.8 Social isolation and cognitive decline resulting from the lack of communication are contributing factors towards dementia. During the pandemic, imposed COVID-19 restrictions are likely to increase the risks of dementia for patients with hearing loss.
Dr Barrie Tan, Senior Consultant and Medical Director of Barrie Tan ENT Head & Neck Surgery said, “The pandemic has affected all of us in more ways than one, especially so for people with hearing loss. Hearing loss should never be a hindrance towards embracing quality life and maintaining relationships. Helping patients find a suitable hearing solution means more than enhancing communication, it is also about helping them maintain relationships and their quality of life.”
Cochlear remains committed to empowering people to benefit from cochlear implant technology, enabling them to live a full and connected life.
The Nucleus Kanso 2 Sound Processor is available from August 2021. To learn more, visit www.cochlear.com.
